About this trial
This study examines whether a digital app can help women manage symptoms of menopause. A total of 426 women with medically confirmed menopausal symptoms are randomly assigned to either use the app in addition to their usual medical care for 24 weeks, or to continue with usual care alone. The app provides evidence-based content and exercises for multimodal menopause management. Participants are followed up over 24 weeks, with the primary outcome assessed at 12 weeks. The main goal is to evaluate whether the app improves menopause-specific quality of life.
Eligibility criteria
Qualifiers
Legal capacity
Ability to provide informed consent
Residency in Germany
Female gender
Disqualifiers
Pregnancy or breastfeeding during the study period
Current hormonal replacement therapy (HRT), initiation of HRT within eight weeks prior to study start and/or planned start of HRT during the study period
Changes in treatment with psychotropic medication within eight weeks prior to study start and/or planned during the study period
Start of psychotherapy within eight weeks prior to study start and/or planned during the study period
Trial design
Treatments tested in this trial
- Menopause App